Cargando…

Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis

Rheumatoid arthritis is a chronic autoimmune syndrome associated with several genetic, epigenetic, and environmental factors affecting the articular joints contributing to cartilage and bone damage. Although etiology of this disease is not clear, several immune pathways, involving immune (T cells, B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Qinghua, Zhou, Chun, Nandakumar, Kutty Selva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103059/ https://www.ncbi.nlm.nih.gov/pubmed/32256192 http://dx.doi.org/10.1155/2020/3830212

Ejemplares similares

Aberrant Activation of Immune and Non-Immune Cells Contributes to Joint Inflammation and Bone Degradation in Rheumatoid Arthritis
por: Nandakumar, Kutty Selva, et al.
Publicado: (2023)

Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis
por: Fang, Qinghua, et al.
Publicado: (2019)

Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues
por: Nandakumar, Kutty Selva
Publicado: (2018)

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis
por: Nandakumar, Kutty Selva, et al.
Publicado: (2006)

Early biomarkers of joint damage in rheumatoid and psoriatic arthritis
por: Mc Ardle, Angela, et al.
Publicado: (2015)

Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in primates and mice
por: Lindh, Ingrid, et al.
Publicado: (2014)

Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview
por: Tanaka, Yoshiya
Publicado: (2021)

Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis
por: Li, Yanpeng, et al.
Publicado: (2020)

Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity
por: Carlsen, Stefan, et al.
Publicado: (2006)

Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells
por: Nandakumar, Kutty Selva, et al.
Publicado: (2004)

Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat
por: Tuncel, Jonatan, et al.
Publicado: (2016)

Polymer Chemistry Defines Adjuvant Properties and Determines the Immune Response against the Antigen or Vaccine
por: Shakya, Akhilesh Kumar, et al.
Publicado: (2023)

Predicting joint damage in rheumatoid arthritis using MRI scanning
por: McQueen, Fiona M, et al.
Publicado: (2009)

Rheumatoid arthritis treatment: the earlier the better to prevent joint damage
por: Monti, Sara, et al.
Publicado: (2015)

Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis
por: Mangnus, Lukas, et al.
Publicado: (2015)

Albumin/Globulin Ratio as Yin–Yang in Rheumatoid Arthritis and Its Correlation to Inflamm-Aging Cytokines
por: Chen, Yong, et al.
Publicado: (2021)

Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies
por: Chen, Yu-Lan, et al.
Publicado: (2018)

Comparative Analysis on Abnormal Methylome of Differentially Expressed Genes and Disease Pathways in the Immune Cells of RA and SLE
por: Fang, Qinghua, et al.
Publicado: (2021)

Chemotaxis of Vδ2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis
por: Mo, Wen-Xiu, et al.
Publicado: (2017)

Human NCF1(90H) Variant Promotes IL-23/IL-17—Dependent Mannan-Induced Psoriasis and Psoriatic Arthritis
por: Li, Yanpeng, et al.
Publicado: (2023)

Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis
por: He, Xiaojuan, et al.
Publicado: (2019)

Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities
por: Karsdal, Morten A, et al.
Publicado: (2011)

Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review
por: Emery, Paul, et al.
Publicado: (2021)

Vaccines and Vaccine Adjuvants for Infectious Diseases and Autoimmune Diseases
por: Nandakumar, Kutty Selva
Publicado: (2023)

Joint damage in rheumatoid arthritis: assessment of a new scoring method
por: Pfeil, Alexander, et al.
Publicado: (2013)

Lower limb joint replacement in rheumatoid arthritis
por: Clement, Nicholas D, et al.
Publicado: (2012)

Epigenetic contributions in the development of rheumatoid arthritis
por: Klein, Kerstin, et al.
Publicado: (2012)

Cartilage and bone damage in rheumatoid arthritis
por: Ostrowska, Monika, et al.
Publicado: (2018)

A Perspective on Oral Immunotherapeutic Tools and Strategies for Autoimmune Disorders
por: Shakya, Akhilesh Kumar, et al.
Publicado: (2023)

Molecular and cellular pathways contributing to brain aging
por: Zia, Aliabbas, et al.
Publicado: (2021)

Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments
por: Maeda, Kazuhiro, et al.
Publicado: (2022)

Gut-joint axis: Gut dysbiosis can contribute to the onset of rheumatoid arthritis via multiple pathways
por: Romero-Figueroa, María del Socorro, et al.
Publicado: (2023)

Variation at interleukin-6 receptor gene is associated to joint damage in rheumatoid arthritis
por: Lopez-Lasanta, Maria, et al.
Publicado: (2015)

Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis
por: Cheung, Peter P, et al.
Publicado: (2016)

Myopenia is associated with joint damage in rheumatoid arthritis: a cross‐sectional study
por: Lin, Jian‐Zi, et al.
Publicado: (2019)

Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis
por: Stavre, Zheni, et al.
Publicado: (2023)

S100A8/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis
por: Kang, Kwi Young, et al.
Publicado: (2014)

Application of cellular gene therapy for rheumatoid arthritis
por: Nakajima, Atsuo
Publicado: (2006)

The Treatment of Joints in Rheumatoid Arthritis
por: Lindsay, James
Publicado: (1907)

Editorial: Systemic lupus erythematosus - predisposition factors, pathogenesis, diagnosis, treatment and disease models
por: Nandakumar, Kutty Selva, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aib40ghqs38c57laa5dh7cfa8p